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In this issue of Immunity, Ng et al. (2009) show that lymphoid-lineage priming occurs in hematopoietic stem
cells and is dependent on the Ikaros transcription factor, as is repression of self-renewal genes during
lymphoid differentiation.Hematopoietic stem cells (HSCs) have
extensive self-renewal potential and the
ability to differentiate into at least eight
distinct cell lineages. Despite intense
investigation, our understanding of how
HSCs choose a differentiated fate is still
in its infancy. Many studies have focused
on defining precursor-progeny relation-
ships through use of cell surface markers
for precursor cell isolation combined with
in vitro or in vivo differentiation assays to
retrospectively examine developmental
potential. Such assays led to the identifi-
cation of a common lymphoid progenitor
(CLP) and a common myeloid progenitor
(CMP, which has myeloid, megakaryo-
cyte [Mk], and erythrocyte [E] potential)
and to the notion that the initial fate choice
of HSCs was between lymphoid and
myeloid differentiation (Wagers et al.,
2002). Recent segregation of the HSC
population (Lineage marker negative,
c-kit+, Sca1+) via surface expression of
the Flt3 receptor led to identification of
a lymphoid-primed multipotent progen-
itor (LMPP), which retains lymphoid and
myeloid differentiation potential but has
a substantially reduced capacity for Mk
and E differentiation. Therefore, LMPPs
appears to represent an intermediate
stage between HSCs and CLPs, indi-
cating that MkE developmental potential
is lost prior to segregation of the lymphoid
and myeloid fates (Luc et al., 2008). In this
issue of Immunity, Ng et al. (2009) provide
molecular evidence supporting this model
of hematopoiesis and identify the Ikaros
transcription factor as a regulator of the
lymphoid gene signature in multipotent
progenitors.
Gene expression analysis in HSCs
and their multipotent progeny has been474 Immunity 30, April 17, 2009 ª2009 Elsevconsistent with the developmental poten-
tial exhibited by these cells. For example,
mRNA transcripts associated with mature
lymphoid and myeloid cells are detected
at low amounts in LMPPs, a process
referred to as ‘‘lineage priming’’ (Mansson
et al., 2007). Indeed, CLPs show evidence
of lymphoid- but not myeloid-lineage
priming whereas CMPs have myeloid-
but not lymphoid-lineage priming (Akashi
et al., 2003). Lineage priming may be the
consequence of alterations in chromatin
structure that allow increased accessi-
bility of these genes to their transcrip-
tional regulators and/or an increase in
expression of the appropriate set of
transcription factors. Because mRNA
transcripts associated with multiple line-
ages have been detected in a single cell,
further lineage restriction appears to
involve the resolution of these conflicting
gene expression programs through
repression of inappropriate genes and/
or reinforcement of lineage-appropriate
genes. Importantly, to date, MkE- and
myeloid-lineage priming have been de-
tected in HSCs; however, lymphoid-
lineage priming has been detected only
at the LMPP stage (Luc et al., 2008).
This skewed lineage priming in HSCs
has been interpreted to mean that the
molecular events underlying the lymphoid
fate choice are initiated late in differentia-
tion, possibly reflecting the late evolution
of the lymphoid lineages.
Ng et al. (2009) identify transcriptional
signatures in HSCs and their multipotent
progeny that reveal a very early onset of
multilineage, including lymphoid, priming
and provide evidence for the current view
of lineage relationships through trans-
criptome-based ‘‘phylogenetic’’ analysis.ier Inc.Global gene expression analysis was
used to compare the transcriptomes
of populations enriched for HSCs,
LMPPs, GMPs, and MEPs and clustering
identified signatures that are unique or
common between sets of these pro-
genitors, for example a stem-myeloid-
lymphoid (s-myly) signature containing
genes common between HSCs, GMPs,
and LMPPs or a differentiated lymphoid
(d-ly) signature containing genes found
only in LMPPs and pro-B lymphocytes.
Through this analysis, a set of lymphoid-
associated mRNA transcripts was identi-
fied that is already primed in the HSC
population. An elegant single-cell analysis
of gene expression was undertaken to
determine the extent of lymphoid-lineage
priming in HSCs and the degree of overlap
between lymphoid-, myeloid-, and eyrth-
roid-lineage priming as well as with stem
cell signature genes. This analysis re-
vealed a similar frequency of HSCs with
lymphoid- or erythroid-lineage priming,
suggesting that these lineages are primed
with equal efficiency in HSCs and con-
currently with the expression of genes
involved in HSC self-renewal. However,
only a small fraction of HSCs was found
to have copriming of lymphoid, myeloid,
and erythroidmRNA transcripts and these
were equally divided between cells with or
without the stem cell signature (presum-
ably representing true HSCs and MPPs,
respectively), suggesting that lineage
priming is a stochastic process.
This study also revealed that the subset
of GMPs lacking the myeloid surface
marker Mac1 and expressing an Ikaros
promoter-GFP reporter expresses both
myeloid and lymphoid mRNA transcripts,
even though GMPs are considered to be
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Figure 1. Modeling HSC Differentiation Based on Patterns of Lineage Priming
HSCs stochastically transcribe low amounts (‘‘priming’’) of genes associated with multiple lineages. An immature subset of HSCs may have these genes in
a ‘‘poised’’ chromatin state. As HSCs differentiate, expression of stem cell genes declines and cells with lineage-restricted priming are likely to adopt the
corresponding fate; the fate of cells that efficiently prime conflicting programs remains to be determined. MEPs express only MkE genes but a more immature
MkE-primed progenitor (MEPP) may exist, with multilineage priming, that is closely related to HSCs. Ikaros (Ik) promotes lymphoid priming in HSCs and their
lymphoid leaning progeny and prevents expression of stem cells genes in LMPPs. Ikaros is required for proper lymphoid specification beyond the LMPPs,
suggesting that lymphoid priming is important for these later cell fate decisions.myeloid-restricted progenitors. Indeed,
the authors show that these cells give
rise to both B and T lymphocytes after
in vivo transfer, indicating that they retain
lymphoid in addition to myeloid differenti-
ation potential. However, quantitative
in vitro assays revealed that these GMPs
efficiently produce T lymphocytes but
are less robust at producing B lympho-
cytes. This finding suggests that B
lymphocyte potential can be lost before
myeloid or T lymphocyte potential and is
consistent with recent experiments that
revealed T lymphocyte and myeloid, but
not B lymphocyte, potential in the earliest
thymic progenitors (Chi et al., 2009).
Therefore, these experiments demon-
strate that a subset of GMPs, which are
likely an immature subset recently derived
from LMPPs, retain a latent lymphoid (T >
B) potential as they undergo restriction to
the myeloid lineage.
Ng et al. (2009) performed a parallel
single-cell gene expression analysis in
HSCs and their multipotent progeny iso-
lated frommice lacking the transcriptional
regulator Ikaros. Ikaros-deficient HSCs
and LMPPs showed a decrease inlymphoid-lineage priming and an increase
in multiple mRNA transcripts associated
with HSC self-renewal. Because Ikaros
is both a transcriptional activator and
repressor, the authors conclude that
Ikaros is a bivalent regulator of cell fate,
activating lymphoid-lineage-associated
genes and repressing HSC-associated
genes. However, direct repression of this
subset of HSC genes by Ikaros remains
to be demonstrated. It is interesting that
a subset of lymphoid mRNA transcripts
that are Ikaros dependent also depend
on the transcription factor E2A, which is
required for development of LMPPs and
for lymphoid-lineage priming (Dias et al.,
2008). Because many of these lymphoid
mRNA transcripts have putative binding
sites for both E2A and Ikaros in their
promoter, it is likely that these transcription
factors function cooperatively to initiate
lymphoid-lineage priming. However, addi-
tional transcription factors may also func-
tion in this process in a combinatorial
manner.
This paper provides important insight
into the hierarchical relationships between
very early progenitors based on patternsImmunityof lineageprimingbut also raisesa number
of interesting questions about hematopoi-
etic cell fate decisions (Figure 1). Does
lineage priming occur equally well in
long-term (LT) and short-term (ST) recon-
stituting HSCs or is lineage priming asso-
ciated with the decision of LT-HSCs to
differentiate? In embryonic stem cells it
has been demonstrated that some genes
are ‘‘poised’’ to be expressed by contain-
ing histone modifications associated with
both active and repressed chromatin (Spi-
vakov and Fisher, 2007). These bivalent
modifications are proposed to allow rapid
activation or repression of a gene based
on the availability of transcriptional regula-
tors. It remains to be determined whether
a subset of HSCs maintains hematopoi-
etic lineage-associated genes in such a
poised state or whether these genes are
in a repressed state and transcription is
initiated only after significant chromatin
remodeling. If hematopoietic genes are
poised in LT-HSCs, then lineage priming
may occur rapidly in the presence of
the correct complement of transcription
factors. Alternatively, the need to remodel
chromatin may delay the activation of30, April 17, 2009 ª2009 Elsevier Inc. 475
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ation. In either scenario, the complement
of transcription factors, rather than
lineage priming itself, may play a direct
role in HSC cell fate determination.
However, the two models may be distin-
guished by whether lineage priming
occurs concomitant with or subsequent
to cell fate decisions.
In this regard, the role of lineage priming
in segregation of the LMPP andMkE fates
remains to be resolved. Because Ikaros is
not required for development of LMPPs
but rather for lymphoid differentiation
from LMPPs, a possible role for
lymphoid-lineage priming appears to be
restricted to cell fate decisions after
segregation of the MkE fate (Ng et al.,
2009; Yoshida et al., 2006). However, it
remains possible that a critical Ikaros-
independent lymphoid gene(s) may func-
tion in repression of the MkE fate. It is
also unclear whether HSCs that coprime
lymphoid- and myeloid- along with
erythroid-lineage genes resolve these
conflicting gene expression programs or
whether they simply fail to undergo further
differentiation (Figure 1). Although the
degree of multilineage copriming appearsFighting the Flu wi
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A wide variety of stimuli induce the
against viruses. In this issue of Im
role for NLRP3 induction of the infla
Influenza A virus is an important human
pathogen that infects millions of people
worldwide in seasonal epidemics and
leads to more than 30,000 deaths annu-
ally in the United States alone (Tauben-
berger and Morens, 2008). The character
of the immune response, and in particular
the innate immune response, is a key
determinant of influenza outcomewherein
innate immunity mediates our essential
476 Immunity 30, April 17, 2009 ª2009 Elsevto be low in this study, this may be due to
the small number of genes examined.
Therefore, analysis of a larger set of
lineage-associated genes may reveal
a higher degree of copriming and a need
for resolution of conflicting gene expres-
sion programs at this stage. Acquisition
of the LMPP fate could be the conse-
quence of HSC differentiation concomi-
tant with a failure of MkE-lineage priming
(i.e., those cells that fail to activate MkE
genes become LMPPs). In this respect,
it is interesting that one of the primed
E lineage genes examined is Gata1,
a transcription factor that is essential for
E development whereas none of the
essential lymphoid transcription factors
are a component of the lymphoid-
lineage-primed set (Crispino, 2005). The
ability to analyze chromatin and global
gene expression patterns in single cells
is a challenging future goal that will be
required to understand how genome
regulation influences cell fate choices.
The identification of s-myly or other multi-
lineage gene programs in progenitors with
defined developmental potential is an
important step in understanding how
multiple lineages arise from HSCs.th Inflammasome
1,*
shington, Seattle, WA 98195, USA
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inflammasome, but little is known
munity, Allen et al. (2009) and Thom
mmasome and protection against in
first-line defense against infection. Path-
ogen-associated molecular patterns
(PAMPs) present within influenza A virus
that are generated during infection are
recognized by three major classes of
pattern-recognition receptors (PRRs),
which form the basis for innate immune
detection of viruses and other microbes.
These PRRs include the Toll-like recep-
tors (TLRs), retinoic acid inducible gene-I
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(RIG-I)-like receptors (RLRs), and the
nucleotide-binding domain-leucine-rich
repeat-containing molecules (NLRs).
Detection of influenza A virus by TLRs or
RLRs lead to the production of type 1
interferons in bronchial epithelial cells
(via RIG-I) and plasmacytoid dendritic
cells (via TLR7) leading to tissue-specific
and systemic antiviral states (Wang
et al., 2007). In general, little is known
